סרטיקן ® 0.25 מ"ג טבליות מסיסות
País: Israel
Idioma: hebreu
Font: Ministry of Health
Alguns documents d’aquest producte actualment no estan disponibles, podeu enviar una sol·licitud al nostre servei d’atenció al client i us ho notificarem tan bon punt puguem obtenir-los.
Enviar sol.licitud.
Enviar sol.licitud.
ingredients actius:
EVEROLIMUS 0.25 MG
Disponible des:
NOVARTIS PHARMA SERVICES AG
Codi ATC:
L04AA18
formulario farmacéutico:
TABLETS DISPERSIBLE
Vía de administración:
PER OS
Fabricat per:
NOVARTIS PHARMA STEIN AG, SWITZERLAND
Grupo terapéutico:
EVEROLIMUS
indicaciones terapéuticas:
Kidney and heart transplantationCertican® is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic renal or cardiac transplant. In kidney and heart transplantation, Certican should be used in combination with ciclosporin for microemulsion and corticosteroids.Liver transplantationCertican is indicated for the prophylaxis of organ rejection in patients receiving a hepatic transplant. In liver transplantation, Certican should be used in combination with tacrolimus and corticosteroids.
Data d'autorització:
2010-02-01
